In breast cancer, tumors, and cell lines, CSE favors cell proliferation and migration under the command of STAT3, a member of JAK/STAT pathway (38); while in a murine model, CSE is stated as controlling the metastatic behavior of breast cancer cells through VEGF-dependent PI3K and MAPK pathways (91). The gene discussed is STAT3; the disease is breast cancer.